Literature DB >> 15117886

TGF-beta signaling and the fibrotic response.

Andrew Leask1, David J Abraham.   

Abstract

The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor-beta (TGF-beta), connective tissue growth factor (CTGF, CCN2), and ED-A fibronectin (ED-A FN) and the antifibrotic proteins tumor necrosis factor-alpha (TNF-alpha) and gamma-interferon (IFN-gamma).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117886     DOI: 10.1096/fj.03-1273rev

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  846 in total

1.  GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation.

Authors:  Jun Ai; Jing Nie; Jiangbo He; Qin Guo; Mei Li; Ying Lei; Youhua Liu; Zhanmei Zhou; Fengxin Zhu; Min Liang; Yongxian Cheng; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 10.121

2.  Absence of mannose-binding lectin prevents hyperglycemic cardiovascular complications.

Authors:  Vasile I Pavlov; Laura R La Bonte; William M Baldwin; Maciej M Markiewski; John D Lambris; Gregory L Stahl
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

Review 3.  Extracellular matrix proteins in hemostasis and thrombosis.

Authors:  Wolfgang Bergmeier; Richard O Hynes
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

4.  TGF-β1 enhances contractility in engineered skeletal muscle.

Authors:  Michael R Weist; Michael S Wellington; Jacob E Bermudez; Tatiana Y Kostrominova; Christopher L Mendias; Ellen M Arruda; Lisa M Larkin
Journal:  J Tissue Eng Regen Med       Date:  2012-02-27       Impact factor: 3.963

5.  Role of immune cells and inflammatory cytokines in regulation of fibrosis around silicone expander implants.

Authors:  Josna Joseph; Mira Mohanty; P V Mohanan
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

6.  Biosimulation of inflammation and healing in surgically injured vocal folds.

Authors:  Nicole Y K Li; Yoram Vodovotz; Patricia A Hebda; Katherine Verdolini Abbott
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-06       Impact factor: 1.547

7.  Blocking IKKα expression inhibits prostate cancer invasiveness.

Authors:  Rubi Mahato; Bin Qin; Kun Cheng
Journal:  Pharm Res       Date:  2010-12-30       Impact factor: 4.200

8.  Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.

Authors:  John F Alcorn; Lisa M Rinaldi; Elizabeth F Jaffe; Mirjam van Loon; Jason H T Bates; Yvonne M W Janssen-Heininger; Charles G Irvin
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

9.  Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.

Authors:  Laura A Johnson; Eva S Rodansky; Andrew J Haak; Scott D Larsen; Richard R Neubig; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

10.  Prostaglandin E2 inhibits α-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A.

Authors:  Loka R K Penke; Steven K Huang; Eric S White; Marc Peters-Golden
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.